... System Prostatic neoplasms Risk assessment Prostate cancer (PCa) is among the most common malignancies in men, and the presence of lymph node involvement (LNI) remains a critical prognostic factor influencing therapeutic decisions [ 1, 2 ]. Although extended pelvic lymph node dissection (ePLND...

... to in the content or advertisements. Antibiotics Focal therapy High-intensity focused ultrasound HIFU Prostatic neoplasms Urinary tract infection Organ-sparing focal therapies of localized prostate cancer aim to efficiently treat intraprostatic cancer lesions and to avoid side effects of whole...

.... Prostatic neoplasms Prostate-specific antigen [-2]pro-prostate specific antigen Prostate Health Index Clinical decision-making Table 1. Study cohort characteristics Table 2. Discriminative ability of biomarkers for predicting PCa Table 3. Univariate and multivariate base...

... hormone-sensitive PC (mHSPC) [ 4 ]. Prostatic neoplasms Castration-resistant Radionuclide imaging Biomarkers © 2017 S. Karger AG, Basel 2017 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Erectile dysfunction Prostatectomy Prostatic neoplasms Urinary incontinence Prostate cancer is the most frequently diagnosed cancer in men in Austria and is estimated...

... to in the content or advertisements. XPD hOGG1 Polymorphism Prostatic neoplasms Susceptibility Meta-analysis Prostate cancer (PCa) is the most common noncutaneous malignancy and the second leading cause of cancer mortality among men in the USA [ 1 ]. Although its etiology remains largely unknown...

...: Men who had a lower percent protein intake and higher percent fat intake had an elevated PSA level, although the magnitude of these associations was small. Prostate-specific antigen Diet Epidemiology Prostatic neoplasms 18 01 2012 20 05 2012 10 7 2012 © 2012 S. Karger...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatitis Prostate-specific antigen Prostatic neoplasms Biopsy, needle...

... improvement. Short-term effects of endocrine therapy on prostate cancer patients with bone metastases should be comprehensively evaluated based upon the entire spectrum of clinical and laboratory findings, including serial changes of serum prostate markers and bone markers as well. Prostatic neoplasms...

... Veterans Affairs Health Care System, Palo Alto, Calif., USA Comparison of Mid-Lobe versus Lateral Systematic Sextant Biopsies in the Detection of Prostate Cancer Keywords Prostatic neoplasms Biopsy Ultrasonography Abstract Objective: Systematic sextant biopsies are a powerful tool in the diagnosis...

... neoplasms Specimen handling, prostatic neoplasms Tissue sampling, prostatic adenocarcinoma Transurethral resection, prostate Abstract Yellow chips were sought in 206 transurethral resection specimens of prostate. 18 (9%) contained yellow chips, and 46 (22%) prostatic adenocarcinomas were present. Yellow...

... of Magnetic Resonance Imaging versus Transrectal Ultrasound in Stages A and B Prostatic Cancer Key Words Prostatic neoplasms Ultrasonic diagnosis Magnetic resonance imaging Abstract The present study was undertaken to compare the ability of magnetic reso­ nance imaging (MRI) and transrectal ultrasound (TRUS...

... Hodgkin’s lymphoma Urogenital neoplasms Kidney neoplasms Bladder neoplasms Prostatic neoplasms Testicular neoplasms A.K. Hemal S.K. Sharma Department of Urology, Post-Graduate Institute of Medical Education and Research, Chandigarh, India Original Paper Urol Int 1994;52:77-81 Urological...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic neoplasms Endocrine treatment Prolactin Prognosis Urol. int. 42: 124-126 (1987) © 1987 S. Karger AG. Basel...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic neoplasms Sarcoma Drug therapy, sarcoma Surgery, prostate...

...-systematic review of the literature, searching Medline using the following key words: ‘Prostatic neoplasms/therapy’ [MeSH], ‘Buserelin’ [MeSH], ‘Goserelin’ [MeSH], ‘Leuprolide’ [MeSH], ‘Triptorelin’ [MeSH], ‘prostate cancer*’ [tiab], and ‘testoster*’ [tiab]. Results: The most commonly used cut-off point...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cryotherapy Prostatic neoplasms Salvage cryotherapy Urologia...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatic neoplasms Prostatectomy...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Hemodialysis Prostatic neoplasms Prostate-specific antigen Mass screening Urologia Internationalis Original Paper...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostatectomy Laparoscopy Prostatic neoplasms Transurethral resection Urinary continence Complications, operative Urologia Internationalis Original Paper Urol Int...